Concepedia

Outcome-based Medication Evaluation

Outcome-Based Medication Evaluation is a systematic assessment method within medication use evaluation that analyzes the effects of pharmacotherapy on patient health outcomes to determine the appropriateness, efficacy, and safety of drug use.

10

Publications

426

Citations

63

Authors

35

Institutions

Publications per year

2017–2026

3

Parents

Publications

10

Maximizing the Adequacy of Medication Treatment in Controlled Trials and Clinical Practice: STAR*D Measurement-Based Care

Madhukar H. Trivedi, A. John Rush, Bradley N. Gaynes et al. · Neuropsychopharmacology · 2007 · 153 citations

, , +13

Use of Functional Analysis Methodology in the Evaluation of Medication Effects

Kimberly Crosland, Jennifer R. Zarcone, Steven E. Lindauer et al. · Journal of Autism and Developmental Disorders · 2003 · 64 citations

, , +8

Development of a core outcome set for effectiveness trials aimed at optimising prescribing in older adults in care homes

Anna Millar, Amrit Daffu-O’Reilly, Carmel Hughes et al. · Trials · 2017 · 63 citations · Full text

, , +15

Evaluation of Potentially Drug-Related Patient-Reported Common Symptoms Assessed During Clinical Medication Reviews: A Cross-Sectional Observational Study

Tim W. A. Schoenmakers, Martina Teichert, Michel Wensing et al. · Drug Safety · 2017 · 31 citations · Full text

, , +15

Outcome Measures in Medication Trials for Substance Use Disorders

David J. McCann, Tatiana Ramey, Phil Skolnick · Current Treatment Options in Psychiatry · 2015 · 31 citations · Full text

, , +16

1–5 of 10

Authors

63

  1. MW
    Michel Wensing

    Radboud University Nijmegen, Netherlands

    1 publications · 31 citations

    1

    h-index

  2. TR
    Tatiana Ramey

    National Institute on Drug Abuse, United States

    1 publications · 31 citations

    1

    h-index

  3. PH
    Peter H. Van Ness

    Yale University, United States

    1 publications · 12 citations

    1

    h-index

  4. JM
    Joris Maesschalck

    Association Pharmaceutique Belge, Belgium

    1 publications · 23 citations

    1

    h-index

  5. JD
    Jan De Lepeleire

    KU Leuven, Belgium

    1 publications · 23 citations

    1

    h-index

1–5 of 63

Institutions

35

  1. National Institutes of Health

    Bethesda, United States

    2 h-index

    4 publications

    246 citations

  2. Bristol-Myers Squibb (United States)

    New York, United States

    1 h-index

    2 publications

    32 citations

  3. Association Pharmaceutique Belge

    Brussels, Belgium

    1 h-index

    2 publications

    46 citations

  4. University of Leeds

    Leeds, United Kingdom

    1 h-index

    2 publications

    126 citations

  5. VA Connecticut Healthcare System

    West Haven, United States

    1 h-index

    2 publications

    24 citations

  6. National Institute on Drug Abuse

    Bethesda, United States

    1 h-index

    3 publications

    93 citations

  7. University of Kansas

    Lawrence, United States

    1 h-index

    6 publications

    384 citations

  8. Columbia University

    New York, United States

    1 h-index

    1 publications

    153 citations

1–8 of 35

Venues

  1. Journal of Aging and Health

    JAH · 1 publications · 12 citations

    1

    h-index

  2. 1

    h-index

  3. Journal of Autism and Developmental Disorders

    1 publications · 64 citations

    1

    h-index

  4. Neuropsychopharmacology

    1 publications · 153 citations

    1

    h-index

  5. Drug Safety

    1 publications · 31 citations

    1

    h-index

1–5